Found: 15
Select item for more details and to access through your institution.
Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 297, doi. 10.1007/s10637-007-9049-4
- By:
- Publication type:
- Article
Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 351, doi. 10.1007/s10637-007-9045-8
- By:
- Publication type:
- Article
Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 343, doi. 10.1007/s10637-006-9033-4
- By:
- Publication type:
- Article
Evaluation of ABT-751 against childhood cancer models in vivo.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 285, doi. 10.1007/s10637-007-9042-y
- By:
- Publication type:
- Article
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 335, doi. 10.1007/s10637-007-9035-x
- By:
- Publication type:
- Article
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 385, doi. 10.1007/s10637-007-9040-0
- By:
- Publication type:
- Article
Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 377, doi. 10.1007/s10637-007-9039-6
- By:
- Publication type:
- Article
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 369, doi. 10.1007/s10637-007-9034-y
- By:
- Publication type:
- Article
Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 327
- By:
- Publication type:
- Article
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 359, doi. 10.1007/s10637-006-9031-6
- By:
- Publication type:
- Article
A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 313, doi. 10.1007/s10637-007-9053-8
- By:
- Publication type:
- Article
Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 391
- By:
- Publication type:
- Article
Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 305, doi. 10.1007/s10637-007-9052-9
- By:
- Publication type:
- Article
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro soft-agar cloning experiments.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 397, doi. 10.1007/s10637-007-9051-x
- By:
- Publication type:
- Article
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 4, p. 357, doi. 10.1007/s10637-007-9047-6
- By:
- Publication type:
- Article